Last reviewed · How we verify

Morning Group

Rush University Medical Center · FDA-approved active Small molecule

Morning Group is a medication that helps regulate sleep-wake cycles.

Morning Group is a medication that helps regulate sleep-wake cycles. Used for Treatment of insomnia.

At a glance

Generic nameMorning Group
Also known asPlacebo Comparator: Placebo
SponsorRush University Medical Center
Drug classMelatonin receptor agonist
TargetMelatonin receptor
ModalitySmall molecule
Therapeutic areaSleep disorder
PhaseFDA-approved

Mechanism of action

It works by influencing the body's natural sleep-wake cycle, also known as the circadian rhythm. This is achieved through its effects on the suprachiasmatic nucleus (SCN), the part of the brain that controls the body's internal clock.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: